Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 99 (5), 1388-1395
- https://doi.org/10.1016/0016-5085(90)91166-4
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Somatostatin does not reduce oesophageal variceal pressure in liver cirrhotics.Gut, 1988
- Vasopressin Therapy for Upper Gastrointestinal Tract HemorrhageArchives of Internal Medicine, 1985
- A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage.BMJ, 1985
- Comparison of Intravenous Somatostatin and Vasopressin Infusions in Treatment of Acute Variceal Hemorrhage†Hepatology, 1984
- Influence of somatostatin on splanchnic haemodynamics in patients with liver cirrhosisClinical Physiology and Functional Imaging, 1984
- SomatostatinNew England Journal of Medicine, 1983
- Somatostatin reduces gastric mucosal blood flow in normal subjects but not in patients with cirrhosis of the liver.Gut, 1983
- Effects of vasopressin and somatostatin on hemodynamics and blood gases in patients with liver cirrhosisCritical Care Medicine, 1982
- Somatostatin Not Helpful in Bleeding Esophageal VaricesNew England Journal of Medicine, 1979
- INFLUENCE OF SOMATOSTATIN ON CARBOHYDRATE DISPOSAL AND ABSORPTION IN DIABETES MELLITUSThe Lancet, 1976